Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Rehberg

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Molecular Pharmacology|April 17, 2008
Atrial natriuretic peptide protects against histamine-induced endothelial barrier dysfunction in vivoRobert Fürst, Martin F Bubik, Peter Bihari, et al.
Cell|July 14, 2015
Photoswitchable Inhibitors of Microtubule Dynamics Optically Control Mitosis and Cell DeathMalgorzata Borowiak, Wallis Nahaboo, Martin Reynders, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 6, 2011
Inhibitor of apoptosis proteins as novel targets in inflammatory processesBettina A Mayer, Markus Rehberg, Annette Erhardt, et al.
Frontiers in Bioengineering and Biotechnology|February 26, 2021
A Bioinspired <i>in vitro</i> Lung Model to Study Particokinetics of Nano-/Microparticles Under Cyclic Stretch and Air-Liquid Interface ConditionsAli Doryab, Mehmet Berat Taskin, Philipp Stahlhut, et al.
Biomaterials|July 13, 2010
The contribution of the capillary endothelium to blood clearance and tissue deposition of anionic quantum dots in vivoMarc Praetner, Markus Rehberg, Peter Bihari, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2013
Transient targeting of phosphoinositide 3-kinase acts as a roadblock in mast cells' route to allergyEmilie Collmann, Thomas Bohnacker, Romina Marone, et al.
Clinical Pharmacology and Therapeutics|March 31, 2025
First-in-Human Single and Multiple Ascending Dose Studies of Balinatunfib, a Small Molecule Inhibitor of TNFR1 Signaling in Healthy ParticipantsNassr Nassr, Faiza Rharbaoui, Dietmar Weitz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 26, 2014
Tissue plasminogen activator promotes postischemic neutrophil recruitment via its proteolytic and nonproteolytic propertiesBernd Uhl, Gabriele Zuchtriegel, Daniel Puhr-Westerheide, et al.
Rheumatology and Therapy|September 14, 2021
Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial DataMarkus Rehberg, Clemens Giegerich, Amy Praestgaard, et al.
Rheumatology and Therapy|October 29, 2021
Correction to: Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial DataMarkus Rehberg, Clemens Giegerich, Amy Praestgaard, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Molecular Pharmacology|April 17, 2008
Atrial natriuretic peptide protects against histamine-induced endothelial barrier dysfunction in vivoRobert Fürst, Martin F Bubik, Peter Bihari, et al.
Cell|July 14, 2015
Photoswitchable Inhibitors of Microtubule Dynamics Optically Control Mitosis and Cell DeathMalgorzata Borowiak, Wallis Nahaboo, Martin Reynders, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 6, 2011
Inhibitor of apoptosis proteins as novel targets in inflammatory processesBettina A Mayer, Markus Rehberg, Annette Erhardt, et al.
Frontiers in Bioengineering and Biotechnology|February 26, 2021
A Bioinspired <i>in vitro</i> Lung Model to Study Particokinetics of Nano-/Microparticles Under Cyclic Stretch and Air-Liquid Interface ConditionsAli Doryab, Mehmet Berat Taskin, Philipp Stahlhut, et al.
Biomaterials|July 13, 2010
The contribution of the capillary endothelium to blood clearance and tissue deposition of anionic quantum dots in vivoMarc Praetner, Markus Rehberg, Peter Bihari, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2013
Transient targeting of phosphoinositide 3-kinase acts as a roadblock in mast cells' route to allergyEmilie Collmann, Thomas Bohnacker, Romina Marone, et al.
Clinical Pharmacology and Therapeutics|March 31, 2025
First-in-Human Single and Multiple Ascending Dose Studies of Balinatunfib, a Small Molecule Inhibitor of TNFR1 Signaling in Healthy ParticipantsNassr Nassr, Faiza Rharbaoui, Dietmar Weitz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 26, 2014
Tissue plasminogen activator promotes postischemic neutrophil recruitment via its proteolytic and nonproteolytic propertiesBernd Uhl, Gabriele Zuchtriegel, Daniel Puhr-Westerheide, et al.
Rheumatology and Therapy|September 14, 2021
Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial DataMarkus Rehberg, Clemens Giegerich, Amy Praestgaard, et al.
Rheumatology and Therapy|October 29, 2021
Correction to: Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial DataMarkus Rehberg, Clemens Giegerich, Amy Praestgaard, et al.
Pageof 7